New concepts in cocaine addiction: the dopamine depletion hypothesis.
- Authors
- Dackis, C A; Gold, M S
- Year
- 1985
- Journal
- Neuroscience and biobehavioral reviews
- PMID
- 2999657
- DOI
- 10.1016/0149-7634(85)90022-3
Euphoric properties of cocaine lead to the development of chronic abuse, and appear to involve the acute activation of central DA neuronal systems. This is based upon known effects of cocaine on DA neurons, and the role played by DA in reward states and self-stimulation behavior. With chronic cocaine use, neurotransmitter and neuroendocrine alterations occur. DA depletion is hypothesized to result from overstimulation of these neurons and excessive synaptic metabolism of the neurotransmitter. DA depletion may underlie dysphoric aspects of cocaine abstinence, and cocaine urges. Neurochemical disruptions caused by cocaine are consistent with the concept of "physical" rather than "psychological" addiction. Possible pharmacological interventions in cocaine addiction are outlined and the psychological approach to these patients is discussed.
No figures extracted from this document.
No chunks โ full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| The aggregate effect of dopamine genes on dependence symptoms among cocaine users: cross-validation of a candidate system scoring approach. | 2012 | 22358648 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Cocaine self-administration attenuates brain glucose metabolism and functional connectivity in rats. | Rowan C et al. | โ | 2025 | โ |
| Dopaminergic Homeostatic Therapy (DHT<sup>โข</sup>) as a Putative Anti-Addiction Seeking Intervention and Early Identification of Genetic Preaddiction with Genetic Addiction Risk Severity (GARS<sup>ยฎ</sup>) Screening. | Lewandrowski KU et al. | โ | 2025 | โ |
| Effects of Biperiden (Cholinergic Muscarinic m1/m4 Receptor Antagonist) on Craving Nicotine: A Proof-Of-Concept Clinical Study. | Rosa Ciutti GL et al. | โ | 2025 | โ |
| Health risks of cocaine adulteration: local anesthetics as modulators of monoamine and organic cation transporters. | Kudlacek O et al. | โ | 2025 | โ |
| Longitudinal disturbances of objective sleep architecture in cocaine use disorder: A translational systematic review. | Medigue I et al. | โ | 2025 | โ |
| Neurospirituality Connectome - Role in Neurology and Reward Deficiency Syndrome (RDS). | Blum K et al. | โ | 2025 | โ |
| Pharmacological Evaluation of Tropane Analogues at the Serotonin Transporter. | Avanes AA et al. | โ | 2025 | โ |
| Seeking Satisfaction Among Israeli Young Adults: The Roles of Gratification, Compensation, Reward Deficiency Syndrome, and Compulsivity in Relation to Addictive Behaviors. | Efrati Y et al. | โ | 2025 | โ |
| Addressing cortex dysregulation in youth through brain health check coaching and prophylactic brain development. | Blum K et al. | โ | 2024 | โ |
| Dopamine Dysregulation in Reward and Autism Spectrum Disorder. | Blum K et al. | โ | 2024 | โ |
| Exercise Influences the Brain's Metabolic Response to Chronic Cocaine Exposure in Male Rats. | Powell A et al. | โ | 2024 | โ |
| Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy. | Zeine F et al. | โ | 2024 | โ |
| Striatal dopamine integrates cost, benefit, and motivation. | Eshel N et al. | โ | 2024 | โ |
| Chiral Resolution of the Enantiomers of the Slow-Onset Dopamine Reuptake Inhibitor CTDP-32476 and Their Activities. | Froimowitz M et al. | โ | 2023 | โ |
| Dopaminergic dysfunction: Role for genetic & epigenetic testing in the new psychiatry. | Blum K et al. | โ | 2023 | โ |
| Evidence for the <i>DRD2</i> Gene as a Determinant of Reward Deficiency Syndrome (RDS). | Blum K et al. | โ | 2023 | โ |
| Exercise Modifies the Brain Metabolic Response to Chronic Cocaine Exposure Inhibiting the Stria Terminalis. | Hanna C et al. | โ | 2023 | โ |
| High intensity interval training exercise increases dopamine D2 levels and modulates brain dopamine signaling. | Tyler J et al. | โ | 2023 | โ |
| Invited Expert Opinion- Bioinformatic and Limitation Directives to Help Adopt Genetic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Required Analytic Evidence to Induce Dopamine Homeostatsis. | Blum K et al. | โ | 2023 | โ |
| Neuroimaging Techniques in Differentiating Parkinson's Disease from Drug-Induced Parkinsonism: A Comprehensive Review. | Pitton Rissardo J et al. | โ | 2023 | โ |
| Opioid use disorder: current trends and potential treatments. | Lee YK et al. | โ | 2023 | โ |
| Reward Deficiency Syndrome Solution System (RDSSS) A Genetically Driven Putative Inducer of "Dopamine Homeostasis" as a Futuristic Alternative to Enhance Rehabilitation Instead of Incarceration. | Blum K et al. | โ | 2023 | โ |
| Emotion recognition in individuals with cocaine use disorder: the role of abstinence length and the social brain network. | Rabin RA et al. | โ | 2022 | โ |
| Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor ยต1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms? | Gondrรฉ-Lewis MC et al. | โ | 2022 | โ |
| Overcoming reward deficiency syndrome by the induction of "dopamine homeostasis" instead of opioids for addiction: illusion or reality? | Blum K et al. | โ | 2022 | โ |
| Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence? | Madigan MA et al. | โ | 2022 | โ |
| The dopamine transporter gene SLC6A3: multidisease risks. | Reith MEA et al. | โ | 2022 | โ |
| Why haven't we solved the addiction crisis? | Blum K et al. | โ | 2022 | โ |
| Hormones can influence drug addiction-A narrative review. | Famitafreshi H et al. | โ | 2021 | โ |
| Influence of Clinical Markers of Dopaminergic Behaviors on Depressive Symptoms During Withdrawal in Cocaine Users. | Cabรฉ J et al. | โ | 2021 | โ |
| Oxidative Stress and Cocaine Intoxication as Start Points in the Pathology of Cocaine-Induced Cardiotoxicity. | Georgieva E et al. | โ | 2021 | โ |
| Psychostimulant use disorder emphasizing methamphetamine and the opioid -dopamine connection: Digging out of a hypodopaminergic ditch. | Blum K et al. | โ | 2021 | โ |
| Translational and Molecular Cytoarchitectural Genetic Guided Therapy to Induce Dopamine Homeostatic Neuro-signaling in Reward Deficiency and Associated Drug and Behavioral Addiction Seeking: A 60 Year Sojourn the Future is Now. | Blum K et al. | โ | 2021 | โ |
| Clinical Trials for Stimulant Use Disorders: Addressing Heterogeneities That May Undermine Treatment Outcomes. | Regier PS et al. | โ | 2020 | โ |
| Electroacupuncture Relieves Pain During Alcohol Withdrawal. | Ye JH et al. | โ | 2020 | โ |
| Medication-assisted therapies for opioid use disorders in patients with chronic pain. | Oesterle TS et al. | โ | 2020 | โ |
| Neurobiology of cue-reactivity, craving, and inhibitory control in non-substance addictive behaviors. | Antons S et al. | โ | 2020 | โ |
| Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome? | Gold MS et al. | โ | 2020 | โ |
| Potential of Glial Cell Modulators in the Management of Substance Use Disorders. | Jones JD | โ | 2020 | โ |
| Treatment resistant opioid use disorder (TROUD): Definition, rationale, and recommendations. | Patterson Silver Wolf DA et al. | โ | 2020 | โ |
| Animal models in addiction research: A dimensional approach. | Lamontagne SJ et al. | โ | 2019 | โ |
| Cues play a critical role in estrous cycle-dependent enhancement of cocaine reinforcement. | Johnson AR et al. | โ | 2019 | โ |
| Dopamine and addiction: what have we learned from 40ย years of research. | Solinas M et al. | โ | 2019 | โ |
| Incentive and dopamine sensitization produced by intermittent but not long access cocaine self-administration. | Kawa AB et al. | โ | 2019 | โ |
| Synaptic and intrinsic plasticity in the ventral tegmental area after chronic cocaine. | Francis TC et al. | โ | 2019 | โ |
| The transition to cocaine addiction: the importance of pharmacokinetics for preclinical models. | Kawa AB et al. | โ | 2019 | โ |
| Understanding the Scientific Basis of Post-traumatic Stress Disorder (PTSD): Precision Behavioral Management Overrides Stigmatization. | Blum K et al. | โ | 2019 | โ |
| [Alveolar hemorrhage and cocaine use]. | Underner M et al. | โ | 2018 | โ |
| Introducing Precision Addiction Management of Reward Deficiency Syndrome, the Construct That Underpins All Addictive Behaviors. | Blum K et al. | โ | 2018 | โ |
| Levodopa prevents the reinstatement of cocaine self-administration in rats via potentiation of dopamine release in the medial prefrontal cortex. | Antinori S et al. | โ | 2018 | โ |
| Our evolved unique pleasure circuit makes humans different from apes: Reconsideration of data derived from animal studies. | Blum K et al. | โ | 2018 | โ |
| Promoting Precision Addiction Management (PAM) to Combat the Global Opioid Crisis. | Blum K et al. | โ | 2018 | โ |
| Cocaine sensitization increases subthreshold activity in dopamine neurons from the ventral tegmental area. | Arencibia-Albite F et al. | โ | 2017 | โ |
| Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape. | Blum K et al. | โ | 2017 | โ |
| Cross-talk between the epigenome and neural circuits in drug addiction. | Mews P et al. | โ | 2017 | โ |
| Deep Brain Stimulation for the Treatment of Aggressive Behaviour: Considerations on Pathophysiology and Target Choice. | Rizzi M et al. | โ | 2017 | โ |
| "Dopamine homeostasis" requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America's drug epidemic. | Blum K et al. | โ | 2017 | โ |
| [Pneumomediastinum and cocaine use]. | Underner M et al. | โ | 2017 | โ |
| Pro-Dopamine Regulator - (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS). | Blum K et al. | โ | 2017 | โ |
| The acute effect of pleasurable music on craving for alcohol: A pilot crossover study. | Mathis WS et al. | โ | 2017 | โ |
| Dopamine D2 gene expression interacts with environmental enrichment to impact lifespan and behavior. | Thanos PK et al. | โ | 2016 | โ |
| Fifty Years in the Development of a Glutaminergic-Dopaminergic Optimization Complex (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome: A Pictorial. | Blum K et al. | โ | 2016 | โ |
| Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review. | Angarita GA et al. | โ | 2016 | โ |
| Adaptations of presynaptic dopamine terminals induced by psychostimulant self-administration. | Siciliano CA et al. | โ | 2015 | โ |
| Age moderates the effect of acute dopamine depletion on passive avoidance learning. | Kelm MK et al. | โ | 2015 | โ |
| A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy in Psychiatry. | Gold MS et al. | โ | 2015 | โ |
| Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner? | Blum K et al. | โ | 2015 | โ |
| Cocaine self-administration disrupts mesolimbic dopamine circuit function and attenuates dopaminergic responsiveness to cocaine. | Siciliano CA et al. | โ | 2015 | โ |
| Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction. | Blum K et al. | โ | 2015 | โ |
| Early-life adversity and adolescent depression: mechanisms involving the ventral striatum. | Goff B et al. | โ | 2015 | โ |
| Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users. | Uosukainen H et al. | โ | 2015 | โ |
| The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery. | Blum K et al. | โ | 2015 | โ |
| The role of mesoaccumbens dopamine in nicotine dependence. | Balfour DJ | โ | 2015 | โ |
| Unexpected results on the role of nucleus accumbens dopamine in stress-induced relapse. | Calu D et al. | โ | 2015 | โ |
| Brain dopaminergic system changes in drug addiction: a review of positron emission tomography findings. | Hou H et al. | โ | 2014 | โ |
| Cocaine Intoxication and Thyroid Storm: Similarity in Presentation and Implications for Treatment. | Lacy ME et al. | โ | 2014 | โ |
| Excessive cocaine use results from decreased phasic dopamine signaling in the striatum. | Willuhn I et al. | โ | 2014 | โ |
| Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS). | Blum K et al. | โ | 2014 | โ |
| Hypothesizing Darkness Induced Alcohol Intake Linked to Dopaminergic Regulation of Brain Function. | Blum K et al. | โ | 2014 | โ |
| Loss of phasic dopamine: a new addiction marker? | Caprioli D et al. | โ | 2014 | โ |
| Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children? | Gold MS et al. | โ | 2014 | โ |
| Paradoxical abatement of striatal dopaminergic transmission by cocaine and methylphenidate. | Federici M et al. | โ | 2014 | โ |
| Tolerance to cocaine in brain stimulation reward following continuous cocaine infusions. | Pudiak CM et al. | โ | 2014 | โ |
| Disrupted topological organization in whole-brain functional networks of heroin-dependent individuals: a resting-state FMRI study. | Jiang G et al. | โ | 2013 | โ |
| The effectiveness of treatments for cocaine dependence in schizophrenic patients: a systematic review. | Sabioni P et al. | โ | 2013 | โ |
| Biperiden (Mโ antagonist) impairs the expression of cocaine conditioned place preference but potentiates the expression of cocaine-induced behavioral sensitization. | Ramos AC et al. | โ | 2012 | โ |
| Does subclinical hyperthyroidism predispose to cocaine addiction? | Vasudevan VN et al. | โ | 2012 | โ |
| How does stress lead to risk of alcohol relapse? | Sinha R | โ | 2012 | โ |
| "Liking" and "wanting" linked to Reward Deficiency Syndrome (RDS): hypothesizing differential responsivity in brain reward circuitry. | Blum K et al. | โ | 2012 | โ |
| Neuropsychiatric Genetics of Happiness, Friendships, and Politics: Hypothesizing Homophily ("Birds of a Feather Flock Together") as a Function of Reward Gene Polymorphisms. | Blum K et al. | โ | 2012 | โ |
| Positron emission tomography molecular imaging of dopaminergic system in drug addiction. | Hou H et al. | โ | 2012 | โ |
| Substance of abuse and movement disorders: complex interactions and comorbidities. | Deik A et al. | โ | 2012 | โ |
| The aggregate effect of dopamine genes on dependence symptoms among cocaine users: cross-validation of a candidate system scoring approach. | Derringer J et al. | โ | 2012 | โ |
| Treatment for tobacco smoking: a new alternative? | Zaparoli JX et al. | โ | 2012 | โ |
| Acoustic startle reduction in cocaine dependence persists for 1 year of abstinence. | Corcoran S et al. | โ | 2011 | โ |
| Alcohol reward, dopamine depletion, and GDNF. | Pickens CL et al. | โ | 2011 | โ |
| Associations between use of cocaine, amphetamines, or psychedelics and psychotic symptoms in a community sample. | Kuzenko N et al. | โ | 2011 | โ |
| Attention-deficit/hyperactivity disorder: is it time to reappraise the role of sugar consumption? | Johnson RJ et al. | โ | 2011 | โ |
| Distinct resting-state brain activities in heroin-dependent individuals. | Zhang Y et al. | โ | 2011 | โ |
| In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery. | Darvesh AS et al. | โ | 2011 | โ |
| Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis. | Blum K et al. | โ | 2011 | โ |
| Neurogenetics and clinical evidence for the putative activation of the brain reward circuitry by a neuroadaptagen: proposing an addiction candidate gene panel map. | Chen TJ et al. | โ | 2011 | โ |
| Repeated mirtazapine nullifies the maintenance of previously established methamphetamine-induced conditioned place preference in rats. | Voigt RM et al. | โ | 2011 | โ |
| Altered small-world brain functional networks and duration of heroin use in male abstinent heroin-dependent individuals. | Yuan K et al. | โ | 2010 | โ |
| Cocaine is low on the value ladder of rats: possible evidence for resilience to addiction. | Cantin L et al. | โ | 2010 | โ |
| Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS). | Blum K et al. | โ | 2010 | โ |
| Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse. | Willuhn I et al. | โ | 2010 | โ |
| Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine Dโ agonist therapy: part 2. | Blum K et al. | โ | 2010 | โ |
| A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion. | Harris DS et al. | โ | 2009 | โ |
| Food addiction? | Gold MS et al. | โ | 2009 | โ |
| Methamphetamine abuse and dentistry. | Hamamoto DT et al. | โ | 2009 | โ |
| Natural products as tools for neuroscience: discovery and development of novel agents to treat drug abuse. | Prisinzano TE | โ | 2009 | โ |
| Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART). | Blum K et al. | โ | 2009 | โ |
| Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction. | Carroll FI et al. | โ | 2009 | โ |
| The role of glutamate and its receptors in mesocorticolimbic dopaminergic regions in opioid addiction. | Guo Y et al. | โ | 2009 | โ |
| A model of reward choice based on the theory of reinforcement learning. | Smirnitskaya IA et al. | โ | 2008 | โ |
| Bupropion hydrochloride versus placebo, in combination with cognitive behavioral therapy, for the treatment of cocaine abuse/dependence. | Shoptaw S et al. | โ | 2008 | โ |
| Dopamine transporter levels in cocaine dependent subjects. | Crits-Christoph P et al. | โ | 2008 | โ |
| Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction. | Rothman RB et al. | โ | 2008 | โ |
| Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform. | Schmitz JM et al. | โ | 2008 | โ |
| Pharmacologic mechanisms of crystal meth. | Kish SJ | โ | 2008 | โ |
| Potentiation of intracranial self-stimulation during prolonged subcutaneous infusion of cocaine. | Hernandez G et al. | โ | 2008 | โ |
| The principles of agonist pharmacotherapy for psychostimulant dependence. | Shearer J | โ | 2008 | โ |
| Conditioned and sensitized responses to stimulant drugs in humans. | Leyton M | โ | 2007 | โ |
| Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions. | Rothman RB et al. | โ | 2007 | โ |
| The role of stress in addiction relapse. | Sinha R | โ | 2007 | โ |
| Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs. | Rothman RB et al. | โ | 2006 | โ |
| Biphasic alterations in serotonin-1B (5-HT1B) receptor function during abstinence from extended cocaine self-administration. | O'Dell LE et al. | โ | 2006 | โ |
| Dual dopamine-5-HT releasers: potential treatment agents for cocaine addiction. | Rothman RB et al. | โ | 2006 | โ |
| Mathematical assessment of properties of precursor-dependent indirect pharmacodynamic response models. | Hazra A et al. | โ | 2006 | โ |
| Neurorobiology and evidence-based biological treatments for substance abuse disorders. | Ivanov IS et al. | โ | 2006 | โ |
| The effects of illicit drug use and HIV infection on sex hormone levels in women. | Cofrancesco J et al. | โ | 2006 | โ |
| Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration. | Rothman RB et al. | โ | 2005 | โ |
| Reduced dopamine terminal function and insensitivity to cocaine following cocaine binge self-administration and deprivation. | Mateo Y et al. | โ | 2005 | โ |
| The contribution of drug history and time since termination of drug taking to footshock stress-induced cocaine seeking in rats. | Sorge RE et al. | โ | 2005 | โ |
| Toxin-induced movement disorders. | Pappert EJ | โ | 2005 | โ |
| Chronic opiate treatment enhances both cocaine-reinforced and cocaine-seeking behaviors following opiate withdrawal. | He S et al. | โ | 2004 | โ |
| Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal. | Broderick PA et al. | โ | 2004 | โ |
| Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies. | Broderick PA et al. | โ | 2004 | โ |
| Cocaine self-administration selectively decreases noradrenergic regulation of metabotropic glutamate receptor-mediated inhibition in dopamine neurons. | Paladini CA et al. | โ | 2004 | โ |
| Evidence for alterations in alpha2-adrenergic receptor sensitivity in rats exposed to repeated cocaine administration. | Baumann MH et al. | โ | 2004 | โ |
| Examining the effect of cerebral perfusion abnormality magnitude on cognitive performance in recently abstinent chronic cocaine abusers. | Browndyke JN et al. | โ | 2004 | โ |
| Immunocytochemical study of the forebrain serotonergic innervation in Sardinian alcohol-preferring rats. | Casu MA et al. | โ | 2004 | โ |
| Long-term opiate effects on amphetamine-induced dopamine release in the nucleus accumbens core and conditioned place preference. | He S et al. | โ | 2004 | โ |
| Neurobiological mechanisms in addictive and psychiatric disorders. | Bruijnzeel AW et al. | โ | 2004 | โ |
| Neurobiologic processes in drug reward and addiction. | Adinoff B | โ | 2004 | โ |
| Opiate tolerance by heroin self-administration: an fMRI study in rat. | Xi ZX et al. | โ | 2004 | โ |
| Recent advances in the pharmacotherapy of cocaine dependence. | Dackis CA | โ | 2004 | โ |
| Relationship of serum prolactin with severity of drug use and treatment outcome in cocaine dependence. | Patkar AA et al. | โ | 2004 | โ |
| Transdermal selegiline and intravenous cocaine: safety and interactions. | Houtsmuller EJ et al. | โ | 2004 | โ |
| Acute and subacute effects of risperidone and cocaine on accumbens dopamine and serotonin release using in vivo microvoltammetry on line with open-field behavior. | Broderick PA et al. | โ | 2003 | โ |
| Biological markers of cocaine addiction: implications for medications development. | Elkashef A et al. | โ | 2003 | โ |
| Cardiovascular disorders associated with cocaine use: myths and truths. | Knuepfer MM | โ | 2003 | โ |
| Effect of chronic "binge cocaine" on basal levels and cocaine-induced increases of dopamine in the caudate putamen and nucleus accumbens of C57BL/6J and 129/J mice. | Zhang Y et al. | โ | 2003 | โ |
| Epidemiology of substance use disorders in women. | Greenfield SF et al. | โ | 2003 | โ |
| Glutamatergic agents for cocaine dependence. | Dackis C et al. | โ | 2003 | โ |
| Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. | Dackis CA et al. | โ | 2003 | โ |
| Relationship between platelet serotonin uptake sites and measures of impulsivity, aggression, and craving among African-American cocaine abusers. | Patkar AA et al. | โ | 2003 | โ |
| The reinstatement model of drug relapse: history, methodology and major findings. | Shaham Y et al. | โ | 2003 | โ |
| Amantadine treatment for cocaine-dependent patients with severe withdrawal symptoms. | Kampman KM | โ | 2002 | โ |
| Decrease in basal dopamine levels in the nucleus accumbens shell during daily drug-seeking behaviour in rats. | Gerrits MA et al. | โ | 2002 | โ |
| Differing effects of the cannabinoid agonist, CP 55,940, in an alcohol or Tween 80 solvent, on prepulse inhibition of the acoustic startle reflex in the rat. | Stanley-Cary CC et al. | โ | 2002 | โ |
| Involvement of serotonin in nicotine dependence: processes relevant to positive and negative regulation of drug intake. | Olausson P et al. | โ | 2002 | โ |
| Lisuride, a dopamine D2 receptor agonist, and anticraving drug expectancy as modifiers of relapse in alcohol dependence. | Schmidt LG et al. | โ | 2002 | โ |
| Serum prolactin and response to treatment among cocaine-dependent individuals. | Patkar AA et al. | โ | 2002 | โ |
| Biphasic effects of selegiline on striatal dopamine: lack of effect on methamphetamine-induced dopamine depletion. | Grasing K et al. | โ | 2001 | โ |
| Cocaine dependence: a disease of the brain's reward centers. | Dackis CA et al. | โ | 2001 | โ |
| Effects of cocaine on basal and pulsatile prolactin levels in rhesus monkeys. | Honorรฉ GM et al. | โ | 2001 | โ |
| Longitudinal investigation of task persistence and sustained attention in children with prenatal cocaine exposure. | Bandstra ES et al. | โ | 2001 | โ |
| Neuroendocrine effects of d-fenfluramine and bromocriptine following repeated smoked cocaine in humans. | Haney M et al. | โ | 2001 | โ |
| Acute and long-term effects of AIDS and injection drug use on gonadal function. | Wahlstrom JT et al. | โ | 2000 | โ |
| A psychological comparison of females with anorexia nervosa and competitive male bodybuilders: body shape ideals in the extreme. | Davis C et al. | โ | 2000 | โ |
| Cardiovascular and hormonal responses to hyperthermic stress in cocaine addicts after a long period of abstinence. | Vescovi PP | โ | 2000 | โ |
| Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients. | Jacobsen LK et al. | โ | 2000 | โ |
| Gonadal hormone levels in injection drug users. | Wahlstrom JT et al. | โ | 2000 | โ |
| Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse. | Froimowitz M et al. | โ | 2000 | โ |
| Substance abuse and withdrawal in the intensive care unit. Contemporary issues. | Jenkins DH | โ | 2000 | โ |
| Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction. | Volkow ND et al. | โ | 1999 | โ |
| Cocaine Addiction: Neurobiology and Related Current Research in Pharmacotherapy. | Panikkar GP | โ | 1999 | โ |
| Cocaine-induced alterations in the density of monoaminergic receptors in the embryonic guinea pig cerebral wall. | Lidow MS et al. | โ | 1999 | โ |
| Effects of nimodipine on extracellular dopamine levels in the rat nucleus accumbens in ethanol withdrawal. | Rossetti ZL et al. | โ | 1999 | โ |
| Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. | Volkow ND et al. | โ | 1999 | โ |
| Limbic activation during cue-induced cocaine craving. | Childress AR et al. | โ | 1999 | โ |
| Neurobiology of tobacco smoking and other addictive disorders. | Gamberino WC et al. | โ | 1999 | โ |
| Neurochemical adaptation to cocaine abuse: reduction of N-acetyl aspartate in thalamus of human cocaine abusers. | Li SJ et al. | โ | 1999 | โ |
| Serotonergic function in cocaine addicts: prolactin responses to sequential D,L-fenfluramine challenges. | Buydens-Branchey L et al. | โ | 1999 | โ |
| Alterations in serotonergic responsiveness during cocaine withdrawal in rats: similarities to major depression in humans. | Baumann MH et al. | โ | 1998 | โ |
| Cannabinoid transmission and reward-related events. | Gardner EL et al. | โ | 1998 | โ |
| Endocrine effects of nicotine administration, tobacco and other drug withdrawal in humans. | Pickworth WB et al. | โ | 1998 | โ |
| Neurological correlates of fetal cocaine exposure. | Chiriboga CA | โ | 1998 | โ |
| Neurological Correlates of Fetal Cocaine Exposure<sup>a</sup>. | Chiriboga CA | โ | 1998 | โ |
| PET imaging studies in drug abuse. | Fowler JS et al. | โ | 1998 | โ |
| Phentermine and fenfluramine. Preclinical studies in animal models of cocaine addiction. | Rothman RB et al. | โ | 1998 | โ |
| Phentermine and Fenfluramine: Preclinical Studies in Animal Models of Cocaine Addiction. | Rothman RB et al. | โ | 1998 | โ |
| Profound neuronal plasticity in response to inactivation of the dopamine transporter. | Jones SR et al. | โ | 1998 | โ |
| Repeated exposure to methylenedioxymethamphetamine (MDMA) alters nucleus accumbens neuronal responses to dopamine and serotonin. | Obradovic T et al. | โ | 1998 | โ |
| The neuropsychiatry of chronic cocaine abuse. | Bolla KI et al. | โ | 1998 | โ |
| What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? | Berridge KC et al. | โ | 1998 | โ |
| Alterations in the spontaneous release of dopamine and the density of the DA D2 receptor mRNA after chronic postnatal exposure to cocaine. | Howard SG et al. | โ | 1997 | โ |
| A randomized double-blind study of carbamazepine in the treatment of cocaine abuse. | Halikas JA et al. | โ | 1997 | โ |
| Bromocriptine for cocaine dependence. A controlled clinical trial. | Handelsman L et al. | โ | 1997 | โ |
| Can cocaine abuse cause parkinsonism? | Dhopesh VP et al. | โ | 1997 | โ |
| Cocaine's effects on neuroendocrine systems: clinical and preclinical studies. | Mello NK et al. | โ | 1997 | โ |
| Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. | Volkow ND et al. | โ | 1997 | โ |
| Elevated plasma norepinephrine after in utero exposure to cocaine and marijuana. | Mirochnick M et al. | โ | 1997 | โ |
| Failure of gammahydroxy butyric acid to stimulate growth hormone secretion in cocaine addicts. | Vescovi PP et al. | โ | 1997 | โ |
| Imaging studies of cocaine in the human brain and studies of the cocaine addict. | Volkow ND et al. | โ | 1997 | โ |
| Involvement of dopamine D2 receptors in the effect of cocaine on sexual behaviour and stretching-yawning of male rats. | Ferrari F et al. | โ | 1997 | โ |
| I. Serotonin (5-HT) within dopamine reward circuits signals open-field behavior. II. Basis for 5-HT--DA interaction in cocaine dysfunctional behavior. | Broderick PA et al. | โ | 1997 | โ |
| Neural mechanisms of tolerance to the effects of cocaine. | Hammer RP et al. | โ | 1997 | โ |
| Physiological and subjective effects of acute cocaine withdrawal (crash) in rats. | Gauvin DV et al. | โ | 1997 | โ |
| Potential antidepressant effects of novel tropane compounds, selective for serotonin or dopamine transporters. | Hemby SE et al. | โ | 1997 | โ |
| Radioligand binding and immunoautoradiographic evidence for a lack of toxicity to dopaminergic nerve terminals in human cocaine overdose victims. | Staley JK et al. | โ | 1997 | โ |
| The meta-chlorophenylpiperazine challenge test in cocaine addicts: hormonal and psychological responses. | Buydens-Branchey L et al. | โ | 1997 | โ |
| A historically controlled trial of tyrosine for cocaine dependence. | Galloway GP et al. | โ | 1996 | โ |
| Chronic cocaine use as a neuropsychiatric syndrome: a model for debate. | Cadet JL et al. | โ | 1996 | โ |
| Endocrine responses during acute nicotine withdrawal. | Pickworth WB et al. | โ | 1996 | โ |
| Management of cocaine abuse and dependence. | Mendelson JH et al. | โ | 1996 | โ |
| Neurobiology of addiction. | Wise RA | โ | 1996 | โ |
| Neurochemical changes in cocaine withdrawal. | Kuhar MJ et al. | โ | 1996 | โ |
| Phentermine pretreatment antagonizes the cocaine-induced rise in mesolimbic dopamine. | Rothman RB et al. | โ | 1996 | โ |
| Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. | Wilson JM et al. | โ | 1996 | โ |
| Absence of acute cocaine interactions with the MAO-B inhibitor selegiline. | Haberny KA et al. | โ | 1995 | โ |
| Amantadine does not reduce cocaine use or craving in cocaine-dependent methadone maintenance patients. | Handelsman L et al. | โ | 1995 | โ |
| A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909. | Rothman RB et al. | โ | 1995 | โ |
| Concurrent cocaine withdrawal is associated with reduced severity of alcohol withdrawal. | Castaneda R et al. | โ | 1995 | โ |
| Effectiveness of adjunct therapies in crack cocaine treatment. | Richard AJ et al. | โ | 1995 | โ |
| Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self-administration. | Wise RA et al. | โ | 1995 | โ |
| Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats. | Wise RA et al. | โ | 1995 | โ |
| Fluctuations in nucleus accumbens dopamine during cocaine self-administration behavior: an in vivo electrochemical study. | Kiyatkin EA et al. | โ | 1995 | โ |
| Functional significance of mesolimbic dopamine. | Kiyatkin EA | โ | 1995 | โ |
| Rhabdomyolysis and hyperthermia after cocaine abuse: a variant of the neuroleptic malignant syndrome? | Daras M et al. | โ | 1995 | โ |
| The role of dopamine in drug abuse viewed from the perspective of its role in motivation. | Di Chiara G | โ | 1995 | โ |
| Tolerance-like attenuation to contingent and noncontingent cocaine-induced elevation of extracellular dopamine in the ventral striatum following 7 days of withdrawal from chronic treatment. | Meil WM et al. | โ | 1995 | โ |
| Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds. | Wise RA et al. | โ | 1995 | โ |
| A three-choice haloperidol-saline-cocaine drug discrimination task in rats. | Gauvin DV et al. | โ | 1994 | โ |
| Blunted oral body temperature response to MK-212 in cocaine addicts. | Lee MA et al. | โ | 1994 | โ |
| Bromocriptine, a D2 receptor agonist, lowers the threshold for rewarding brain stimulation. | Knapp CM et al. | โ | 1994 | โ |
| Cocaine alters the onset and maintenance of maternal behavior in lactating rats. | Kinsley CH et al. | โ | 1994 | โ |
| Dopamine receptor density, sensitivity and mRNA levels are altered following self-administration of cocaine in the rat. | Laurier LG et al. | โ | 1994 | โ |
| Effects of prenatal cocaine exposure upon postnatal development of neostriatal dopaminergic function. | Leslie CA et al. | โ | 1994 | โ |
| Effects of repeated cocaine injections on cochlear function. | Shivapuja BG et al. | โ | 1994 | โ |
| Lisuride reduces intravenous cocaine self-administration in rats. | Pulvirenti L et al. | โ | 1994 | โ |
| Opiate reinforcement processes: re-assembling multiple mechanisms. | Bozarth MA | โ | 1994 | โ |
| Peripheral benzodiazepine receptors are decreased during cocaine withdrawal in humans. | Javaid JI et al. | โ | 1994 | โ |
| Pharmacotherapy of cocaine abuse: preclinical development. | Witkin JM | โ | 1994 | โ |
| Psychological correlates of frequency and type of drug use among jail inmates. | Fishbein DH et al. | โ | 1994 | โ |
| Selective reduction in dopamine turnover in the rat frontal cortex and hypothalamus during withdrawal from repeated cocaine exposure. | Karoum F et al. | โ | 1994 | โ |
| Serum prolactin levels and treatment outcome in cocaine dependence. | Weiss RD et al. | โ | 1994 | โ |
| The dopamine D2 receptor gene: a genetic risk factor in substance abuse. | Comings DE et al. | โ | 1994 | โ |
| The effects of acute and chronic cocaine administration on paced responding in intact and gonadectomized male and female Wistar rats. | van Haaren F | โ | 1994 | โ |
| The effects of lisuride on mood and sleep during acute withdrawal in stimulant abusers: a preliminary report. | Gillin JC et al. | โ | 1994 | โ |
| A hypothesis for a common neurochemical basis for alcohol and drug disorders. | Miller NS et al. | โ | 1993 | โ |
| Alterations in the dopaminergic receptor system after chronic administration of cocaine. | Alburges ME et al. | โ | 1993 | โ |
| Amperozide, a 5-HT2 antagonist, attenuates craving for cocaine by rats. | McMillen BA et al. | โ | 1993 | โ |
| A neurochemical basis for alcohol and other drug addiction. | Miller NS et al. | โ | 1993 | โ |
| Behavioral response to buspirone in cocaine and phencyclidine withdrawal. | Giannini AJ et al. | โ | 1993 | โ |
| Biosynthesis of dopamine and serotonin in the rat brain after repeated cocaine injections: a microdissection mapping study. | Baumann MH et al. | โ | 1993 | โ |
| Cocaine attenuates puberty acceleration in female house mice. | Chen CJ et al. | โ | 1993 | โ |
| Cocaine enhances the changes in extracellular dopamine in nucleus accumbens associated with reinforcing stimuli: a high-speed chronoamperometric study in freely moving rats. | Kiyatkin EA | โ | 1993 | โ |
| Cocaine: evidence for NMDA- and opioid-mediated antinociception in the tail-flick test. | Ushijima I et al. | โ | 1993 | โ |
| Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine. | Burger LY et al. | โ | 1993 | โ |
| Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. | Volkow ND et al. | โ | 1993 | โ |
| Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous heroin self-administration in rats. | Kiyatkin EA et al. | โ | 1993 | โ |
| Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites. | Morissette M et al. | โ | 1993 | โ |
| Effect of cocaine on the production of puberty-accelerating pheromone by male mice. | Chen CJ et al. | โ | 1993 | โ |
| Effects of acute and chronic cocaine on the activity of tuberoinfundibular dopamine neurons in the rat. | Baumann MH et al. | โ | 1993 | โ |
| Hyperthermia and endorphins. | Vescovi PP et al. | โ | 1993 | โ |
| Molecular alterations in the neostriatum of human cocaine addicts. | Hurd YL et al. | โ | 1993 | โ |
| Monoamine uptake inhibitors alter cocaine pharmacokinetics. | Tella SR et al. | โ | 1993 | โ |
| Motoric signs of CNS dysfunction associated with alcohol and cocaine withdrawal. | Bauer LO | โ | 1993 | โ |
| Neuropsychological deficits in abstinent cocaine abusers: preliminary findings after two weeks of abstinence. | Berry J et al. | โ | 1993 | โ |
| Prenatal cocaine administration stimulates fetal brain tyrosine hydroxylase activity. | Meyer JS et al. | โ | 1993 | โ |
| Progress in psychiatry (2). | Michels R et al. | โ | 1993 | โ |
| The P50 component of the auditory evoked potential and subtypes of schizophrenia. | Boutros N et al. | โ | 1993 | โ |
| Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. | Weiss F et al. | โ | 1992 | โ |
| Cardiovascular complications of cocaine abuse. | Perper JA et al. | โ | 1992 | โ |
| Cocaine euphoria, dysphoria, and tolerance assessed using drug-induced changes in brain-stimulation reward. | Frank RA et al. | โ | 1992 | โ |
| Crystal methamphetamine abuse: a concern to oral and maxillofacial surgeons. | Lee CY et al. | โ | 1992 | โ |
| Dopaminergic responsivity during cocaine abstinence: a pilot study. | McDougle CJ et al. | โ | 1992 | โ |
| Effect of cocaine use on the fetus. | Volpe JJ | โ | 1992 | โ |
| Effects of cocaine on testicular structure in the rat. | Rodriguez MC et al. | โ | 1992 | โ |
| Effects of cocaine on the contents of neurohypophyseal hormones in the plasma and in different brain structures in rats. | Sarnyai Z et al. | โ | 1992 | โ |
| Exaggerated pressor response to treadmill exercise in chronic cocaine abusers with left ventricular hypertrophy. | Cigarroa CG et al. | โ | 1992 | โ |
| Hyperthermia in sauna is unable to increase the plasma levels of ACTH/cortisol, beta-endorphin and prolactin in cocaine addicts. | Vescovi PP et al. | โ | 1992 | โ |
| Increased CSF HVA with craving in long-term abstinent cocaine abusers. | Knoblich G et al. | โ | 1992 | โ |
| Long-term frontal brain metabolic changes in cocaine abusers. | Volkow ND et al. | โ | 1992 | โ |
| Long-term influence of d-amphetamine on mesolimbic brain-stimulation reward: comparison to chronic haloperidol and naloxone effects. | Borowski TB et al. | โ | 1992 | โ |
| Molecular mechanisms associated with cocaine effects. Possible relationships with effects of ethanol. | Ritz MC et al. | โ | 1992 | โ |
| Neural mechanisms of drug reinforcement. | Koob GF | โ | 1992 | โ |
| Neurobiology of cocaine abuse. | Woolverton WL et al. | โ | 1992 | โ |
| Neurochemical correlates of cocaine and ethanol self-administration. | Weiss F et al. | โ | 1992 | โ |
| Neuropharmacology of cocaine and ethanol dependence. | Koob GF et al. | โ | 1992 | โ |
| Neuropsychiatric disorders: investigation of schizophrenia and substance abuse. | Volkow ND et al. | โ | 1992 | โ |
| Opposite actions of oxytocin and vasopressin in the development of cocaine-induced behavioral sensitization in mice. | Sarnyai Z et al. | โ | 1992 | โ |
| Prevalence of cocaine use among residents of New York City who committed suicide during a one-year period. | Marzuk PM et al. | โ | 1992 | โ |
| Apparent synaptic dopamine deficiency induced by withdrawal from chronic cocaine treatment. | Robertson MW et al. | โ | 1991 | โ |
| Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine. | Parsons LH et al. | โ | 1991 | โ |
| Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. | Satel SL et al. | โ | 1991 | โ |
| Cocaine addiction: psychology and neurophysiology. | Gawin FH | โ | 1991 | โ |
| Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence. | Weddington WW et al. | โ | 1991 | โ |
| Dopamine receptors mediate cocaine-induced temperature responses in spontaneously hypertensive and Wistar-Kyoto rats. | Rockhold RW et al. | โ | 1991 | โ |
| Endocrine complications of AIDS and drug addiction. | Brown LS et al. | โ | 1991 | โ |
| GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine. | Rothman RB et al. | โ | 1991 | โ |
| Lack of neurochemical evidence for neurotoxic effects of repeated cocaine administration in rats on brain monoamine neurons. | Yeh SY et al. | โ | 1991 | โ |
| Medical and dental implications of cocaine abuse. | Lee CY et al. | โ | 1991 | โ |
| Medicalizing the drug war. | Fishbein DH | โ | 1991 | โ |
| Sex differences in locomotor activity after acute and chronic cocaine administration. | van Haaren F et al. | โ | 1991 | โ |
| The dopamine hypothesis of the reinforcing properties of cocaine. | Kuhar MJ et al. | โ | 1991 | โ |
| The effect of maternal cocaine use on the fetus: changes in antepartum fetal heart rate tracings. | Tabor BL et al. | โ | 1991 | โ |
| An update on selected organic mental syndromes. | Dickson LR et al. | โ | 1990 | โ |
| Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats. | Wise RA et al. | โ | 1990 | โ |
| Chronic cocaine and rat brain catecholamines: long-term reduction in hypothalamic and frontal cortex dopamine metabolism. | Karoum F et al. | โ | 1990 | โ |
| Dopaminergic involvement in the cocaine-induced up-regulation of benzodiazepine receptors in the rat caudate nucleus. | Goeders N et al. | โ | 1990 | โ |
| Dopaminergic sensitivity and cocaine abuse: response to apomorphine. | Hollander E et al. | โ | 1990 | โ |
| Effect of cocaine on rat pineal melatonin synthesis in vivo and in vitro. | Oxenkrug GF et al. | โ | 1990 | โ |
| Effects of acute and subacute cocaine administration on the CNS dopaminergic system in Wistar-Kyoto and spontaneously hypertensive rats: II. Dopamine receptors. | Lim DK et al. | โ | 1990 | โ |
| Effects of acute and subacute cocaine administration on the CNS dopaminergic system in Wistar-Kyoto and spontaneously hypertensive rats: III. Dopamine uptake. | Lim DK et al. | โ | 1990 | โ |
| Effects of acute and subacute cocaine administration on the CNS dopaminergic system in Wistar-Kyoto and spontaneously hypertensive rats: I. Levels of dopamine and metabolites. | Yu ZJ et al. | โ | 1990 | โ |
| Effects of chronic cocaine abuse on postsynaptic dopamine receptors. | Volkow ND et al. | โ | 1990 | โ |
| Hyperprolactinemia and risk for relapse of cocaine abuse. | Teoh SK et al. | โ | 1990 | โ |
| Multiple, but not acute, infusions of cocaine alter the release of prolactin in male rats. | Pilotte NS et al. | โ | 1990 | โ |
| Myocardial infarction during cocaine withdrawal. | Del Aguila C et al. | โ | 1990 | โ |
| Neurodynamics of relapse prevention: a neuronutrient approach to outpatient DUI offenders. | Brown RJ et al. | โ | 1990 | โ |
| Neuroendocrine measures of dopaminergic function in chronic cocaine users. | Lee MA et al. | โ | 1990 | โ |
| Pharmacologic approaches to the treatment of cocaine dependence. | Taylor WA et al. | โ | 1990 | โ |
| Postcocaine depression and sensitization of brain-stimulation reward: analysis of reinforcement and performance effects. | Kokkinidis L et al. | โ | 1990 | โ |
| Priapism associated with intranasal cocaine abuse. | Fiorelli RL et al. | โ | 1990 | โ |
| Quantitative EEG correlates of crack cocaine dependence. | Alper KR et al. | โ | 1990 | โ |
| Serum prolactin levels during extended cocaine abstinence. | Swartz CM et al. | โ | 1990 | โ |
| The diagnosis of alcohol and cannabis dependence (addiction) in cocaine dependence (addiction). | Miller NS et al. | โ | 1990 | โ |
| The influence of cocaine self-administration on in vivo dopamine and acetylcholine neurotransmission in rat caudate-putamen. | Hurd YL et al. | โ | 1990 | โ |
| The phenomenology of food cravings. | Weingarten HP et al. | โ | 1990 | โ |
| Adolescent dual diagnosis: a 12-step transformational model. | Chatlos JC | โ | 1989 | โ |
| Adverse health consequences of cocaine abuse. | Cregler LL | โ | 1989 | โ |
| A review of the respiratory effects of smoking cocaine. | Ettinger NA et al. | โ | 1989 | โ |
| Bromocriptine and amantadine in cocaine detoxification. | Giannini AJ et al. | โ | 1989 | โ |
| Chlordiazepoxide alters intravenous cocaine self-administration in rats. | Goeders NE et al. | โ | 1989 | โ |
| Clinical ratings and plasma HVA during cocaine abstinence. | Martin SD et al. | โ | 1989 | โ |
| Cocaine abuse and treatment. | Pollack MH et al. | โ | 1989 | โ |
| Cocaine: clinical pharmacology and toxicology. | Farrar HC et al. | โ | 1989 | โ |
| Cocaine-induced cocaine craving. | Jaffe JH et al. | โ | 1989 | โ |
| Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbens: an in vivo microdialysis study. | Hurd YL et al. | โ | 1989 | โ |
| Effects of bromocriptine pretreatment on subjective and physiological responses to i.v. cocaine. | Kumor K et al. | โ | 1989 | โ |
| Endocrine alterations associated with the abuse of cocaine. | Dax EM | โ | 1989 | โ |
| Etiology of alcoholism: relevance of prenatal hormonal influences on the brain, anomalous dominance, and neurochemical and pharmacological brain asymmetry. | Backon J | โ | 1989 | โ |
| Myocardial ischemia during cocaine withdrawal. | Nademanee K et al. | โ | 1989 | โ |
| Quantitative urine testing. A new tool for diagnosing and treating cocaine use. | Tennant F et al. | โ | 1989 | โ |
| 800-COCAINE: origin, significance, and findings. | Roehrich H et al. | โ | 1988 | โ |
| A comparison of self-reported symptoms and DSM-III-R criteria for cocaine withdrawal. | Brower KJ et al. | โ | 1988 | โ |
| Amantadine: evaluation of reinforcing properties and effect on cocaine self-injection in baboons. | Sannerud CA et al. | โ | 1988 | โ |
| Anterior pituitary, adrenal, and gonadal hormones during cocaine withdrawal. | Mendelson JH et al. | โ | 1988 | โ |
| A primer on neurotransmitters and cocaine. | Daigle RD et al. | โ | 1988 | โ |
| Behavioral cross-sensitization between cocaine and enkephalin in the A10 dopamine region. | DuMars LA et al. | โ | 1988 | โ |
| Chronic cocaine enhances defensive behaviour in the laboratory mouse: involvement of D2 dopamine receptors. | Filibeck U et al. | โ | 1988 | โ |
| Cocaine abuse treated with phenelzine. | Golwyn DH | โ | 1988 | โ |
| Cocaine and central monoaminergic neurotransmission: a review of electrophysiological studies and comparison to amphetamine and antidepressants. | Pitts DK et al. | โ | 1988 | โ |
| Cocaine self-administration appears to be mediated by dopamine uptake inhibition. | Ritz MC et al. | โ | 1988 | โ |
| Differentiation of cocaine toxicity: role of the toxicology drug screen. | Quandt CM et al. | โ | 1988 | โ |
| Drug use in the chemically dependent. How to avoid relapse to addiction. | Mulry JT et al. | โ | 1988 | โ |
| Effects of cocaine on release and uptake of dopamine in vivo: differentiation by mathematical modeling. | Nicolaysen LC et al. | โ | 1988 | โ |
| Histories of substance abuse in patients with postpsychotic depressions. | Siris SG et al. | โ | 1988 | โ |
| Intravenous cocaine: psychiatric effects, biological mechanisms. | Sherer MA | โ | 1988 | โ |
| Neurochemical interactions of cocaine with dopaminergic systems. | Galloway MP | โ | 1988 | โ |
| Pharmacological adjuncts in the treatment of opioid and cocaine addicts. | Herridge P et al. | โ | 1988 | โ |
| Repeated cocaine administration results in supersensitivity of striatal D-2 dopamine autoreceptors to pergolide. | Dwoskin LP et al. | โ | 1988 | โ |
| The effect of chronic cocaine on self-stimulation train-duration thresholds. | Frank RA et al. | โ | 1988 | โ |
| The human sexual response and alcohol and drugs. | Miller NS et al. | โ | 1988 | โ |
| The interactive effects of cocaine and imipramine on self-stimulation train-duration thresholds. | Frank RA et al. | โ | 1988 | โ |
| A blood marker for pharmacodynamic tolerance to alcohol. | Miller NS | โ | 1987 | โ |
| Bromocriptine. | Roehrich H et al. | โ | 1987 | โ |
| Cocaine. | Mofenson HC et al. | โ | 1987 | โ |
| Cocaine induced secretion of ACTH, beta-endorphin, and corticosterone. | Moldow RL et al. | โ | 1987 | โ |
| Placental abruption associated with cocaine use: case report. | Landy HJ et al. | โ | 1987 | โ |
| Single-dose bromocriptine reverses cocaine craving. | Dackis CA et al. | โ | 1987 | โ |
| The relationship of addiction, tolerance, and dependence to alcohol and drugs: a neurochemical approach. | Miller NS et al. | โ | 1987 | โ |
| The role of reward pathways in the development of drug dependence. | Wise RA | โ | 1987 | โ |
| Carbamazepine for treatment-resistant depressions? | Madakasira S | โ | 1986 | โ |
| Haloperidol-induced dystonia in cocaine addicts. | Kumor K et al. | โ | 1986 | โ |
| Medical complications of cocaine abuse. | Cregler LL et al. | โ | 1986 | โ |
| More on self-medication and drug abuse. | Dackis CA et al. | โ | 1986 | โ |
| Pharmacological approaches to cocaine addiction. | Dackis CA et al. | โ | 1985 | โ |